Revenue (Tables)

6 Months Ended

Mar. 31, 2023

Revenue From Contract With Customer [Abstract]

Summary of Revenues Disaggregated by Product Classification and Reportable Segment

The following table presents the Company’s revenues disaggregated by product classification and by reportable segment.

	Three Months Ended March 31,				Six Months Ended March 31,
(In thousands)	2023		2022		2023		2022
Medical Device
Product sales	$	7,914	$	6,441	$	16,294	$	13,229
Royalties		8,073		8,358		15,482		15,244
License fees		1,356		1,486		2,712		2,699
Research, development and other		2,364		2,168		4,237		4,189
Medical Device Revenue		19,707		18,453		38,725		35,361
In Vitro Diagnostics
Product sales		7,436		7,523		13,290		13,079
Research, development and other		55		130		116		669
In Vitro Diagnostics Revenue		7,491		7,653		13,406		13,748
Total Revenue	$	27,198	$	26,106	$	52,131	$	49,109